New gel dressing aims to heal stubborn leg wounds

NCT ID NCT07335861

Recruiting now Disease control Sponsor: NuScience Medical Biologics, LLC Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 01, 2026 · Updated 3 times

Summary

This study tests a special wound dressing called Hyalomatrix, made from hyaluronic acid, to see if it helps heal chronic venous leg ulcers faster than standard care alone. About 122 adults with leg ulcers that haven't healed for at least 4 weeks will take part. The main goal is to see if more wounds close completely within 12 weeks using the new dressing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Hyalomatrix (a hyaluronic acid-based wound dressing)
What this could lead to: If it works, this could provide a new, effective option to help heal stubborn leg ulcers faster.
What could go wrong: This is a relatively small, early-stage trial. The device may not heal ulcers better than standard care alone, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC WOUNDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ulcer of lower limbs Varicose Ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC WOUNDS VENOUS LEG ULCER

Contacts and locations

Locations

MedCentris of Alexandria
RECRUITING

Alexandria, Louisiana, 71301, United States
MedCentris of Cleveland
RECRUITING

Cleveland, Mississippi, 38732, United States
MedCentris of Pineville
RECRUITING

Pineville, Louisiana, 71360, United States
MedCentris of Vidaila
RECRUITING

Vidalia, Louisiana, 71373, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.